EFFICACY and ACCEPTABILITY of HIGH FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) VERSUS ELECTROCONVULSIVE THERAPY (ECT) for MAJOR DEPRESSION: A SYSTEMATIC REVIEW and META-ANALYSIS of RANDOMIZED TRIALS.

EFFICACY AND ACCEPTABILITY OF HIGH FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (rTMS) VERSUS ELECTROCONVULSIVE THERAPY (ECT) FOR MAJOR DEPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS.

Filed under: Depression Treatment

Depress Anxiety. 2013 Jan 24;
Berlim MT, Van den Eynde F, Daskalakis ZJ

Clinical trials comparing the efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (HF-rTMS) and electroconvulsive therapy (ECT) for treating major depression (MD) have yielded conflicting results. As this may have been the result of limited statistical power, we have carried out this meta-analysis to examine this issue. We searched the literature for randomized trials on head-to-head comparisons between HF-rTMS and ECT from January 1995 through September 2012 using MEDLINE, EMBASE, PsycINFO, Cochrane Central Register of Controlled Trials, and SCOPUS. The main outcome measures were remission rates, pre-post changes in depression ratings, as well as overall dropout rates at study end. We used a random-effects model, Odds Ratios (OR), Number Needed to Treat (NNT), and Hedges’ g effect sizes. Data were obtained from 7 randomized trials, totalling 294 subjects with MD. After an average of 15.2 HF-rTMS and 8.2 ECT sessions, 33.6% (38/113) and 52% (53/102) of subjects were classified as remitters (OR = 0.46; p = 0.04), respectively. The associated NNT for remission was 6 and favoured ECT. Also, reduction of depressive symptomatology was significantly more pronounced in the ECT group (Hedges’ g = -0.93; p = 0.007). No differences on dropout rates for HF-rTMS and ECT groups were found. In conclusion, ECT seems to be more effective than HF-rTMS for treating MD, although they did not differ in terms of dropout rates. Nevertheless, future comparative trials with larger sample sizes and better matching at baseline, longer follow-ups and more intense stimulation protocols are warranted.
HubMed – depression

 

YOUTH GENETIC VULNERABILITY TO MATERNAL DEPRESSIVE SYMPTOMS: 5-HTTLPR AS MODERATOR OF INTERGENERATIONAL TRANSMISSION EFFECTS IN A MULTIWAVE PROSPECTIVE STUDY.

Filed under: Depression Treatment

Depress Anxiety. 2013 Jan 24;
Oppenheimer CW, Hankin BL, Young JF, Smolen A

BACKGROUND: Maternal depressive symptoms are a strong predictor of increases in depressive symptoms in offspring, yet knowledge of individual differences that may moderate the association between youth and maternal symptoms is still relatively scant. Youth genetic susceptibility to maternal depressive symptoms in particular is a nearly unexplored area of research. METHODS: This study used a multiwave prospective design and lagged hierarchical linear modeling analyses to examine whether youth 5-HTTLPR genotype moderated the longitudinal association between mother and youth depressive symptoms in a community sample (N = 241 youth). Maternal and youth symptoms were assessed every 3 months over 1 year (five waves of data). RESULTS: Youth 5-HTTLPR interacted with idiographic elevations in maternal depressive symptoms (elevations relative to mothers’ average level of symptoms) to predict prospective increases in youth symptoms 3 months later. Youth with the SS genotype experienced greatest increases in depressive symptoms when exposed to elevations in maternal symptoms. Youth 5-HTTLPR did not interact with maternal nomothetic elevations in depressive symptoms (severity of symptoms compared to the sample as a whole). CONCLUSION: These findings advance knowledge on genetic susceptibility for intergenerational transmission of depression between mothers and their children.
HubMed – depression

 

Factors influencing the prescription of drugs of different price levels.

Filed under: Depression Treatment

Pharmacoepidemiol Drug Saf. 2013 Jan 24;
Semark B, Engström S, Brudin L, Tågerud S, Fredlund K, Borgquist L, Petersson G

PURPOSE: Socioeconomic factors have been suggested to influence the prescribing of newer and more expensive drugs. In the present study, individual and health care provider factors were studied in relation to the prevalence of differently priced drugs. METHODS: Register data for dispensed drugs were retrieved for 18?486 individuals in a county council in Sweden. The prevalence of dispensed drugs was combined with data for the individual’s gender, age, education, income, foreign background, and type of caregiver. For each of the diagnostic groups (chronic obstructive pulmonary disease [COPD], depression, diabetes, and osteoporosis), selected drugs were dichotomized into cost categories, lower and higher price levels. Univariate and multivariate logistic regressions were performed using cost category as the dependent variable and the individual and provider factors as independent variables. RESULTS: In all four diagnostic groups, differences were observed in the prescription of drugs of lower and higher price levels with regard to the different factors studied. Age and gender affected the prescription of drugs of lower and higher price levels more generally, except for gender in the osteoporosis group. Income, education, foreign background, and type of caregiver affected prescribing patterns but in different ways for the different diagnostic groups. CONCLUSIONS: Certain individual and provider factors appear to influence the prescribing of drugs of different price levels. Because the average price for the cheaper drugs versus more costly drugs in each diagnostic group was between 19% and 69%, there is a risk that factors other than medical needs are influencing the choice of drug. Copyright © 2013 John Wiley & Sons, Ltd.
HubMed – depression

 

Active Treatment of Depression (Norton Professional Books) by O'Connor, Richard

$4.81
End Date: Saturday Sep-28-2019 15:12:26 PDT
Buy It Now for only: $4.81
Buy It Now | Add to watch list

 

Diagnosis and Treatment of Chronic Depression *NEW*
$6.98
End Date: Wednesday Oct-2-2019 12:27:44 PDT
Buy It Now for only: $6.98
Buy It Now | Add to watch list

 

Depression and Its Treatment, Paperback by Greist, John H.; Jefferson, James ...
$10.60
End Date: Friday Oct-11-2019 4:54:17 PDT
Buy It Now for only: $10.60
Buy It Now | Add to watch list

 

Related Depression Treatment Information…